AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8585370
Drug: Imitation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imitation of therapy
Trial: 2693026
Drug: R1 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R1 (50 mg/d, p. o; total dose: 18.25 g/yr/case)
Trial: 2693026
Drug: R2 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R2 (20 mg/d, p. o; total dose: 3.6 g/6mos/case)
Trial: 2693026
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (riboflavin 50 mg/d, p. o.)
Trial: 558950
Drug: Chlorpromazine (CPZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ, 12.5 mg)
Trial: 558950
Drug: Amobarbital (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amobarbital (100 mg)
Trial: 28825853
Drug: Non-platinum-based chemotherapy
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-platinum-based chemotherapy (NPBC) followed by platinum-based chemotherapy (PBC) at subsequent relapse (experimental arm)
Trial: 28825853
Drug: Standard reverse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard reverse treatment sequence (control arm)
Trial: 18511076
Drug: Overall (All
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall (All Antidepressants)
Trial: 16670691
Drug: B6 -50
RxNorm normalized name: vitamin B6 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B6 -50 (50 mg vitamin B6 daily for 14 days)
Trial: 16670691
Drug: B6 -100
RxNorm normalized name: vitamin B6 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B6 -100 (100 mg vitamin B6 daily for 14 days)
Trial: 9737359
Drug: Antithyroid drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid drug plus thyroxine for 18 months
Trial: 2498658
Drug: Theophylline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (10 mg per kilogram of body weight per day), administered orally for two months
Trial: 2498658
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered for two months
Trial: 29654929
Drug: Community health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community health workers (CHWs) assisting patients with hypertension, using video narratives from patients who have controlled their BP through diet, exercise, and medication adherence. Participants met with CHWs 5 times (twice in person and three times telephonically).
Trial: 22420423
Drug: Doxorubicin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin monotherapy
Trial: 22420423
Drug: Epirubicin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin monotherapy
Trial: 20216467
Drug: Carbohydrate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (25 g)
Trial: 20216467
Drug: Protein (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein (25 g)
Trial: 2248076
Drug: Moclobemide (100‐350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (100‐350 mg daily)
Trial: 2248076
Drug: Tranylcypromine (10‐30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranylcypromine (10‐30 mg daily)
Trial: 6775209
Drug: Aminophylline (350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (350 mg per tablet, 2 tablets)
Trial: 6775209
Drug: Mixture (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixture (75 mg theophylline, 112.5 mg diprophylline, 112.5 mg proxyphylline per tablet, 2 tablets)
Trial: 6871070
Drug: Regular coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular coffee (8 cups/day for 4 weeks, 504 mg caffeine)
Trial: 29866129
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g fat (Calogen®) per kg body weight orally
Trial: 26751791
Drug: Epidural dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural dexmedetomidine (3 ml loading dose at 0.5 μg kg(‐1) and continuous 80 μg in 150 ml levobupivacaine at 3 ml h(‐1) for two days)
Trial: 26751791
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (3 ml loading dose at 0.03 mg kg(‐1) and continuous 4.5 mg in 150 ml levobupivacaine at 3 ml h(‐1) for two days)
Trial: 10325486
Drug: 0.05% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% tretinoin gel
Trial: 7782114
Drug: Pentamidine aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentamidine aerosol (300 mg)
Trial: 7782114
Drug: Pentamidine aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentamidine aerosol + Roxithromycin (300 mg t.i.d.)
Trial: 7782114
Drug: Roxithromycin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (300 mg t.i.d.)
Trial: 6781659
Drug: Photochemotherapy maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photochemotherapy maintenance treatment once a week
Trial: 6781659
Drug: Photochemotherapy maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photochemotherapy maintenance treatment once every three weeks
Trial: 6781659
Drug: Regular maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular maintenance treatment
Trial: 6781659
Drug: No regular
RxNorm normalized name: Aveeno Regular Bath
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No regular maintenance treatment
Trial: 27940571
Drug: Assertive Community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assertive Community Treatment (ACT) plus Treatment as Usual (TAU)
Trial: 15170977
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IFL and bevacizumab
Trial: 12752559
Drug: Non-hypotensive haemorrhage
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-hypotensive haemorrhage (5.6 +/- 1.2 ml kg-1 body weight)
Trial: 30044438
Drug: Almond snack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almond snack (56.7 g/day; 364 kcal; n = 38)
Trial: 30044438
Drug: Graham cracker
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graham cracker control (77.5 g/day; 338 kcal/d; n = 35)
Trial: 19889469
Drug: Intensive multifactorial
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive multifactorial treatment (stepwise implementation of behavior modification, pharmacological therapy targeting hyperglycaemia, hypertension, dyslipidaemia, and proteinuria)
Trial: 16268465
Drug: CVL type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVL type (peripherally inserted central catheters, untunneled CVL, tunneled exteriorized CVL, subcutaneous ports)
Trial: 12297918
Drug: Intravenous prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous prostaglandin E1 (PGE1), n = 18
Trial: 12297918
Drug: No PGE1
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No PGE1 treatment (PGE1(-) group), n = 26
Trial: 11074998
Drug: Compression therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression therapy alone (active control)
Trial: 8777102
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion (240 kJ h‐1, infused over 1‐2 h before anaesthesia)
Trial: 2000818
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg beta-carotene/d orally
Trial: 6653137
Drug: Actifed Compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actifed Compound
Trial: 29142294
Drug: GnRH 10
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH 10 μg
Trial: 29142294
Drug: GnRH 50
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH 50 μg
Trial: 29142294
Drug: GnRH 100
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH 100 μg
Trial: 29142294
Drug: GnRH (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH (all doses)
Trial: 27084861
Drug: Coconut oil
RxNorm normalized name: Coconut Oil
DrugBank: Coconut oil (DB14322)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coconut oil pulling (10 ml for 10 minutes)
Trial: 27084861
Drug: Chlorhexidine mouthwash
RxNorm normalized name: chlorhexidine Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine mouthwash (5 ml for 1 minute)
Trial: 27084861
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (5 ml for 1 minute)
Trial: 23006479
Drug: High-dose ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ascorbic acid intravenously before exercise
Trial: 20339913
Drug: Capecitabine 1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine 1,250 mg/m2 (1,000 mg/m2 in patients >65 years) BID on days 1-14 q3w
Trial: 15907777
Drug: Active dose
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active dose of alcohol (0.65 g/kg)
Trial: 11821453
Drug: Trastuzumab 4
RxNorm normalized name: TRASTUZUMAB 440MG/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab 4 mg/kg loading dose, followed by 2 mg/kg weekly
Trial: 11821453
Drug: Trastuzumab 8
RxNorm normalized name: trastuzumab
DrugBank: Trastuzumab (DB00072)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Trastuzumab 8 mg/kg loading dose, followed by 4 mg/kg weekly
Trial: 7717559
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg/kg bolus plus infusion of 150 micrograms.kg‐1.min‐1)
Trial: 8455371
Drug: Monoclonal antibody
RxNorm normalized name: Monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody against human C5a
Trial: 26506890
Drug: Personalized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized treatment strategy based on patient information
Trial: 25676405
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia only in group G
Trial: 25676405
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (GP and G)
Trial: 20731585
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied during scaling
Trial: 20731585
Drug: No EMLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No EMLA cream applied during scaling
Trial: 19902797
Drug: Combined supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined supplement of 40 mg of zinc as zinc gluconate and 40 mg of iron as ferrous sulphate
Trial: 19902797
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of elemental iron as ferrous sulphate
Trial: 10664922
Drug: Duloxetine 20
RxNorm normalized name: duloxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 20 mg bid, escalated to 30 mg bid, then to 40 mg bid
Trial: 7817443
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (short-term intensive weekly instillation)
Trial: 7817443
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of short-term and 3-year protocols
Trial: 3041327
Drug: Morphine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (10 mg i.m.)
Trial: 30364350
Drug: Metformin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin treatment (n = 7)
Trial: 21081801
Drug: L-tryptophan 500
RxNorm normalized name: L-TRYPTOPHAN 500MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan 500 mg twice daily and Essentiale forte 3 times a day for 4 weeks
Trial: 21081801
Drug: Melatonin 5
RxNorm normalized name: melatonin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 5 mg twice a day and Essentiale forte 3 times a day for 4 weeks
Trial: 16198932
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.8 g/kg/day)
Trial: 12456423
Drug: Nalbuphine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 4 mg (Group N)
Trial: 12456423
Drug: Droperidol 0.625
RxNorm normalized name: droPERidol 0.625 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.625 mg plus nalbuphine 4 mg (Group ND)
Trial: 2569323
Drug: Prescription Information
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription Information Leaflets (PILs) distributed by pharmacists or general practitioners
Trial: 2569323
Drug: No Prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Prescription Information Leaflets (Control)
Trial: 25803783
Drug: BCAA and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA and arginine supplementation (0.17 g/kg BCAA and 0.04 g/kg arginine)
Trial: 21327794
Drug: L +
RxNorm normalized name: Citracal + D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L + A (leg exercises before elbow flexor training)
Trial: 19739491
Drug: Enriched formula
RxNorm normalized name: STRESS FORMULA 500,BIOTIN ENRICHED TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enriched formula (Kcal: 75/100 ml, proteins: 2 g/100 ml)
Trial: 19739491
Drug: Standard formula
RxNorm normalized name: Standard formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard formula (Kcal: 67/100 ml, proteins: 1.4 g/100 ml)
Trial: 15037328
Drug: Gatifloxacin 400
RxNorm normalized name: gatifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 400 mg once daily
Trial: 15037328
Drug: Gatifloxacin 200
RxNorm normalized name: gatifloxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 200 mg once daily
Trial: 11319653
Drug: Sibutramine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (10 mg/day) with a low-fat low-energy individualized diet (600 kcal/day deficit)
Trial: 9874862
Drug: Sufentanil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (10 micrograms) added to 12.5 mg of 0.5% bupivacaine
Trial: 7857761
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitors (enalapril, captopril)
Trial: 348532
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 600 mg
Trial: 31668721
Drug: 1.5 L
RxNorm normalized name: NUTREN 1.5 LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 L of Sterofundin ISO (Reference arm A)
Trial: 31668721
Drug: 0.5 L
RxNorm normalized name: AIR 20.5 L in 100 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 L of 4% Gelaspan® (Isoeffective arm B)
Trial: 31668721
Drug: 0.5 L
RxNorm normalized name: AIR 20.5 L in 100 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 L of 4% Gelaspan® and 1 L of Sterofundin ISO (Isovolumetric arm C)
Trial: 31163434
Drug: Uric acid
RxNorm normalized name: Uric acid
DrugBank: Uric acid (DB08844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uric acid 1,000 mg
Trial: 25845864
Drug: delafloxacin 300
RxNorm normalized name: delafloxacin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delafloxacin 300 mg i.v. (therapeutic)
Trial: 25845864
Drug: delafloxacin 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delafloxacin 900 mg i.v. (supratherapeutic)
Trial: 25845864
Drug: moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moxifloxacin 400 mg orally (positive control)
Trial: 24158584
Drug: Monitored group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monitored group (no further treatment)
Trial: 22264450
Drug: glucose syrup/sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glucose syrup/sucrose (glc/suc)
Trial: 16305977
Drug: benazepril 20
RxNorm normalized name: benazepril 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benazepril 20 mg/day
Trial: 16305977
Drug: benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benazepril 10 mg/day plus valsartan 80 mg/day
Trial: 2496173
Drug: Zidovudine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (250 mg every 4 hours)
Trial: 2496173
Drug: Ribavirin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (800 mg or 600 mg daily)
Trial: 710312
Drug: Combined low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined low-dose heparin and acetylsalicyl-lysine (given intravenously)
Trial: 710312
Drug: Increased heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased heparin dosage (3 X 7500 IU/24 h)
Trial: 710312
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not receiving any heparin)
Trial: 31414266
Drug: Parent-based weight-loss
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-based weight-loss treatment for children with ASD (PBT-ASD)
Trial: 25730000
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (kidney-reinforcing and blood-activating), N = 35
Trial: 23618450
Drug: 1 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 session daily (OD)
Trial: 23618450
Drug: 1 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 session weekly with optional deliberate practice (WD)
Trial: 23618450
Drug: 1 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 session weekly (C)
Trial: 23618450
Drug: 3 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 sessions daily (TD)
Trial: 21067912
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and magnesium infusions (Ca/Mg(+))
Trial: 21067912
Drug: No calcium
RxNorm normalized name: DPBS 1X, NO CALCIUM, NO MAGNESIUM
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No calcium and magnesium infusions (Ca/Mg(-))
Trial: 15001406
Drug: Mean time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean time to analgesic administration
Trial: 11315920
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus medroxy progesterone acetate (hormone therapy)
Trial: 9278766
Drug: Cumulative minimum
RxNorm normalized name: sipuleucel-T
DrugBank: Sipuleucel-T (DB06688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative minimum thermal isoeffect dose (equivalent minutes at 43 degrees C)
Trial: 9278766
Drug: MINTIME >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MINTIME > 42 degrees C (first treatment session)
Trial: 9278766
Drug: %sensors >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: %sensors > 43 degrees C (peak, second treatment session)
Trial: 8315435
Drug: Interferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2a (gradually escalating doses from 3 to 36 x 10(6) U subcutaneously administered daily)
Trial: 8315435
Drug: Interferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2a (daily)
Trial: 8315435
Drug: Interferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2a (daily) + vinblastine (0.15 mg/kg every 3 weeks)
Trial: 3099564
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg BID
Trial: 3099564
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg HS
Trial: 3099564
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg HS